Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)

Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3) Publisher Pubmed

Seyyedebrahimi SS¹ ; Khodabandehloo H¹ ; Nasli Esfahani E^{2, 3} ; Meshkani R^{1, 2, 3}

Show Affiliations

1. Department of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Diabetologica Published:2018

Abstract

Oxidative stress plays a pivotal role in the pathogenesis of type 2 diabetes (T2D). In vitro and animal studies have shown that resveratrol exerts an antioxidant effect, but clinical trials addressing this effect in patients with T2D are limited. The aim of this study was to determine whether resveratrol supplementation affects oxidative stress markers in a randomized, placebo-controlled, double-blind clinical trial. © 2018, Springer-Verlag Italia S.r.l., part of Springer Nature.

Style	Citing Format
MLA	Seyyedebrahimi SS, et al.. "Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)." Acta Diabetologica, vol. 55, no. 10, 2018, pp. 1087-.
APA	Seyyedebrahimi SS, Khodabandehloo H, Nasli Esfahani E, Meshkani R (2018). Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3). Acta Diabetologica, 55(10), 1087-.
Chicago	Seyyedebrahimi SS, Khodabandehloo H, Nasli Esfahani E, Meshkani R. "Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)." Acta Diabetologica 55, no. 10 (2018): 1087-.
Harvard	Seyyedebrahimi SS et al. (2018) 'Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)', Acta Diabetologica, 55(10), pp. 1087-.
Vancouver	Seyyedebrahimi SS, Khodabandehloo H, Nasli Esfahani E, Meshkani R. Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3). Acta Diabetologica. 2018;55(10):1087-.
BibTex	@article{ author = {Seyyedebrahimi SS and Khodabandehloo H and Nasli Esfahani E and Meshkani R}, title = {Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)}, journal = {Acta Diabetologica}, volume = {55}, number = {10}, pages = {1087-}, year = {2018} }
RIS	TY - JOUR AU - Seyyedebrahimi SS AU - Khodabandehloo H AU - Nasli Esfahani E AU - Meshkani R TI - Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3) JO - Acta Diabetologica VL - 55 IS - 10 SP - 1087 EP - PY - 2018 ER -

Style

Citing Format

MLA

Seyyedebrahimi SS, et al.. "Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)." Acta Diabetologica, vol. 55, no. 10, 2018, pp. 1087-.

APA

Seyyedebrahimi SS, Khodabandehloo H, Nasli Esfahani E, Meshkani R (2018). Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3). Acta Diabetologica, 55(10), 1087-.

Chicago

Seyyedebrahimi SS, Khodabandehloo H, Nasli Esfahani E, Meshkani R. "Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)." Acta Diabetologica 55, no. 10 (2018): 1087-.

Harvard

Seyyedebrahimi SS et al. (2018) 'Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)', Acta Diabetologica, 55(10), pp. 1087-.

Vancouver

Seyyedebrahimi SS, Khodabandehloo H, Nasli Esfahani E, Meshkani R. Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3). Acta Diabetologica. 2018;55(10):1087-.

BibTex

@article{ author = {Seyyedebrahimi SS and Khodabandehloo H and Nasli Esfahani E and Meshkani R}, title = {Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)}, journal = {Acta Diabetologica}, volume = {55}, number = {10}, pages = {1087-}, year = {2018} }

RIS

TY - JOUR
AU - Seyyedebrahimi SS
AU - Khodabandehloo H
AU - Nasli Esfahani E
AU - Meshkani R
TI - Correction To: The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Acta Diabetologica, (2018), 55, 4, (341-353), 10.1007/S00592-017-1098-3)
JO - Acta Diabetologica
VL - 55
IS - 10
SP - 1087
EP -
PY - 2018
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract